Categoría: Articulos
-
The British Society for Genetic Medicine guidance on managing incidental findings identified during rare disease genomic testing
BackgroundGenomic testing will occasionally identify a highly actionable genetic variant or other finding that is not related to the reason for testing. Such incidental findings may be relevant to the patient undergoing testing or to their family membe…
-
Everolimus for the treatment of neuropsychological deficits in tuberous sclerosis complex: findings from the TRON multicentre randomised controlled trial
WHAT IS ALREADY KNOWN ON THIS TOPICOveractivation of mammalian target of rapamycin (mTOR) is central to the pathogenesis of tuberous sclerosis complex (TSC), and mTOR inhibitors are effective treatments for many of its manifestations, but efficacy fo…
-
Everolimus for the treatment of neuropsychological deficits in tuberous sclerosis complex: findings from the TRON multicentre randomised controlled trial
BackgroundMammalian target of rapamycin (mTOR) inhibitors are effective treatments for tumours and epilepsy in tuberous sclerosis complex (TSC). This study aimed to determine the effects of the mTOR inhibitor everolimus and a placebo on neuropsychologi…
-
Testing is underway on vaccines to intercept brewing colon cancer before it takes root
Dr. Stacy Norton was only 7 years old when her mother died of colon cancer, one of several family members struck by aggressive tumors at unusually young ages. Decades later, Norton rolled up her sleeve to help test if a new kind of vaccine might protec…
-
Testing is underway on vaccines to intercept brewing colon cancer before it takes root
Dr. Stacy Norton was only 7 years old when her mother died of colon cancer, one of several family members struck by aggressive tumors at unusually young ages. Decades later, Norton rolled up her sleeve to help test if a new kind of vaccine might protec…
-
Rapid genomic sequencing in the NICU: Who to test and why
European Journal of Human Genetics, Published online: 06 August 2026; doi:10.1038/s41431-026-02207-6Rapid genomic sequencing in the NICU: Who to test and why
-
Human genome milestone opens door for personalized genomics
Scientists have reconstructed the complete genome of a real person, with full sets of chromosomes from each parent, a breakthrough expected to advance research, improve the diagnosis of genetic diseases and make personalized genomics routine in medical…
-
Human genome milestone opens door for personalized genomics
Scientists have reconstructed the complete genome of a real person, with full sets of chromosomes from each parent, a breakthrough expected to advance research, improve the diagnosis of genetic diseases and make personalized genomics routine in medical…
-
First complete marmoset genome will enable research on Alzheimer’s and neurodegenerative diseases
To study complex diseases like Alzheimer’s, scientists and clinicians analyze how genes change and malfunction in other species. Marmosets, a species of tiny monkey from South America, have become an important animal model for understanding disease, bu…
-
First complete marmoset genome will enable research on Alzheimer’s and neurodegenerative diseases
To study complex diseases like Alzheimer’s, scientists and clinicians analyze how genes change and malfunction in other species. Marmosets, a species of tiny monkey from South America, have become an important animal model for understanding disease, bu…